RFX5 in cancer: context-dependent molecular functions and emerging translational relevance - Top-Institutions - MDSpire

RFX5 in cancer: context-dependent molecular functions and emerging translational relevance

  • By

  • Li Zhang

  • Shanmei Du

  • Kui Liu

  • July 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    City of Hope Comprehensive Cancer Center
    City of Hope Comprehensive Cancer Center

    Duarte, California

    Key Differentiators

    • Oncology

  • #2

    Dana-Farber/Harvard Cancer Center
    Dana-Farber/Harvard Cancer Center

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Oncology

  • #4

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Oncology

  • #5

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

Original Source(s)

RFX5 in cancer: context-dependent molecular functions and emerging translational relevance

  • by Li Zhang, Shanmei Du, Kui Liu

  • July 1, 2026

Related Content

Out“FOX”ing cancer: the implications of FOXC2 as a putative predictive biomarker for cancer immunotherapy

ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target

Breast Cancer Incidence in Asian American, Native Hawaiian, and Pacific Islander Populations